Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Strahlenther Onkol ; 186(8): 411-22, 2010 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-20803281

RESUMO

BACKGROUND: Until the mid of this century, 33% of the Western population will be > or = 65 years old. The percentage of patients being > or = 80 years old with today 5% will triple until 2050. Therefore, radiation oncologists must be familiar with special geriatric issues to meet the increasing demand for multidisciplinary cooperation and to offer useful and individual treatment concepts. PATIENTS AND METHODS: This review article will provide basic data on the definition, identification and treatment of geriatric cancer patients. RESULTS: The geriatric patient is defined by typical multimorbidity (15 items) and by age-related increased vulnerability. Best initial identification of geriatric patients will be provided by assessment including the Barthel Index evaluating self-care and activity in daily life, by the Mini-Mental Status Test that will address cognitive pattern, and by the Timed "Up&Go" Test for evaluation of mobility. As for chemotherapy, standard treatment was associated with increased toxicity, consequently, dose modifications and supportive treatment are of special importance. CONCLUSION: Geriatric cancer patients need to be identified by special assessment instruments. Due to increased toxicity following chemotherapy, supportive measures seem important. Radiation treatment as a noninvasive and outpatient-based treatment remains an important and preferable option.


Assuntos
Comportamento Cooperativo , Avaliação Geriátrica , Geriatria/tendências , Comunicação Interdisciplinar , Neoplasias/radioterapia , Dinâmica Populacional , Radioterapia (Especialidade)/tendências , Atividades Cotidianas/classificação , Idoso , Idoso de 80 Anos ou mais , Antineoplásicos/uso terapêutico , Antineoplásicos/toxicidade , Terapia Combinada , Comorbidade , Indicadores Básicos de Saúde , Humanos , Entrevista Psiquiátrica Padronizada , Neoplasias/tratamento farmacológico , Medição de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA